type here...

Grey Wolf Therapeutics Closes USD 49M Series B Financing

Ralph Ellison
By Ralph Ellison

-



Grey Wolf Therapeutics Oxford UK based biotechnology company focused on generating entirely novel anti tumour immune responses through targeted cancer neoantigen creation raises USD 49M Series B funding The round led by Pfizer Ventures



Source link

Ralph Ellison
Ralph Ellison

Latest news

As the browser wars heat up, here are the hottest alternatives to Chrome and Safari in 2025

Google Chrome and Apple’s Safari currently dominate the web browser market, with Chrome holding a significant share due...
Tech

It’s Not Just Epstein. MAGA Is Angry About a Lot of Things

When President Donald Trump loses the support of posters on The Donald, it’s notable, to say the least....
Gadgets

Office problems on Windows 10? Microsoft’s response will soon be “upgrade to 11.”

Gadgets

Chrome OS is “combining” with Android, but what does that mean?

Tech

GM’s Final EV Battery Strategy Copies China’s Playbook: Super Cheap Cells

General Motors has just announced its latest and likely final piece in what now appears to be a...

Rainmaker partners with Atmo to squeeze more rain from clouds

Cloud seeding startup Rainmaker is partnering with Atmo, an AI-powered meteorology startup, the companies exclusively told Tech Zone...

Must read

You might also likeRELATED
Recommended to you

Tech Zone Daily provide you with the latest breaking news and updates straight from the Technology industry.

© Copyright - TechZoneDaily